Core Scientific Inc vs Dolby Laboratories, Inc. — how do they compare? Core Scientific Inc trades at $20.4 (market cap $6.25B), while Dolby Laboratories, Inc. trades at $61.82 (market cap $5.82B). The key difference: Core Scientific Inc and Dolby Laboratories, Inc. are close in size by market cap, and Dolby Laboratories, Inc. pays a 2.32% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals.
| CORZ | DLB | |
|---|---|---|
Market Cap | $6.25B | $5.82B |
Sector | Technology | Industrials |
52-Week High | $29.16 | $75.62 |
52-Week Low | $13.55 | $48.51 |
Enterprise Value | $8.78B | $5.19B |
Dividend Yield | — | 2.32% |
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $21.01, down 0.19% on the day, with technical indicators showing a bearish trend despite neutral oscillators. The company reported Q2 2026 revenue growth but missed earnings expectations with a significant net loss of -$1.4 billion for 2026. Recent news highlights a major partnership with AMD for AI infrastructure development, potentially driving future revenue growth through colocation services.
While analyst consensus remains strongly bullish with an 86% buy rating and $35.88 price target, fundamental risks include persistent negative profit margins and substantial cash burn. The AMD partnership offers significant upside potential, but investors must weigh execution risks against the company's current unprofitability and competitive pressures in the data center market.
Dolby Laboratories (DLB) trades at $61.77, up 1.4% today, with a bullish technical trend and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, including Q2 2026 EPS of $0.69 versus $0.67 expected. Revenue remains stable around $1.3 billion annually, with robust gross margins of 87.61%. Recent news highlights growth in Dolby Atmos and automotive licensing, though near-term revenue volatility persists.
DLB offers a compelling valuation with a P/E of 26.29 below the analyst target of $87.50, implying significant upside. Key risks include licensing deal timing and competitive pressures in audio-video tech. Institutional sentiment is positive, with 47% of analysts rating it a Buy, but investors should monitor execution on Q4 growth guidance.
Trailing returns across standard periods
Latest headlines on both assets
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →